Patient advocacy groups have many different roles. They are educators, they provide a support system for individuals and families of people living with illness, they lobby for increased research, and are increasingly providing funding to biotech companies to encourage further research and development of promising, and potentially life-saving therapies. At the 2009 BIO International Convention, we met with patients and patient advocates to learn more about how advocacy groups are working together with biotech researchers to promote innovative research and creation of therapies that may one d
BIOtech Now’s Tracy Krughoff talks to Dr. Kim Hunter-Schaedle, Chief Scientific Officer of the Children’s Tumor Foundation, which is dedicated to ending neurofibromatosis through research.
BIOtech Now’s Tracy Krughoff talks with Steve Perrin, Chief Executive Officer and Chief Scientific Officer of the ALS Therapy Development Institute, which is one of the advocacy organizations presenting at the upcoming BIO CEO & Investor Conference, being held Feb 8-9 in New York City.
Biotech Now’s Tracy Krughoff talks to Dr. Marc Hurlbert, who is Director of the Avon Foundation Breast Cancer Crusade.